Tag: Stocks
-
Investorplace lists 10 dividend stocks you should consider
I don’t hold any stock in the companies on this list but I’m going to take a close look and see if maybe I need to add one or two to my portfolio. Here’s their list. Click the link to read their rationale. Hormel Foods (NYSE:HRL) Texas Instruments (NASDAQ:TXN) Mastercard (NYSE:MA) Starbucks (NASDAQ:SBUX) Lockheed Martin (NYSE:LMT) J.P. Morgan (NYSE:JPM) Northern Trust (NASDAQ:NTRS)…
-
Number of retail investors continue to climb
Retail investors are increasing in number and plowing more money into the markets. In June, so-called retail investors bought nearly $28 billion of stocks and exchange-traded funds on a net basis, according to data from Vanda Research’s VandaTrack, the highest monthly amount deployed since at least 2014. That even trumped the amount retail traders spent…
-
Are investors overly optimistic?
Investors expecting returns of 17.5% after inflation in the coming years? Wow. In a recent survey of 750 U.S. individual investors, Natixis Investment Managers found these people expect to earn 17.3% this year, after inflation. That might not sound like pie in the sky. The S&P 500 returned 18.4% last year, counting dividends, and is up 15.9%…
-
Short sellers are staying away from financial stocks
How long can we expect financial sector stocks to continue to climb? Short-sellers held just 1.57% of financial sector stocks at the end of May, the lowest percentage of any of the S&P 500’s 11 groups, according to an analysis by S&P Global Market Intelligence. That compares to an average of 2.21% of shares in…
-
The Yield – Week ending June 18, 2021
Stocks drop for the week, oil prices hit a high, jobless claims increase, the year of the individual investor, Microsoft names new board chairman, IBM closes an acquisition, Sonoco expands recycling, and Verizon gets a contract. All that including my weekly portfolio update and dividend news
-
Update: Supreme Court refuses to hear J&J appeal
I’m sure that will cause the stock to decline just a bit. The Supreme Court on Tuesday declined to consider a Johnson & Johnson appeal that sought to challenge a $2.1 billion civil judgment awarded to 20 women who alleged the company’s talcum baby powder caused ovarian cancer. The court rejected the J&J appeal in a…